Answers are grounded in this paper and cite their sources.
Collectively, these data identify kinetic and functional differences in diabetic wound monocyte/macrophages and demonstrate that selective targeting of CD11b⁺Ly6CHi monocyte/macrophages is a viable therapeutic strategy for inflammation in diabetic wounds.
No takes yet. Share an insight, caveat, or question.
Kimball et al. (2018) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: